34 results on '"Bañuls S"'
Search Results
2. A genome-wide association study on liver stiffness changes during hepatitis c virus infection cure
- Author
-
Corma-Gómez, A, Macías Sánchez, Juan, Rivero, A., Rivero-Juárez, A., Santos, I. de los, Reus-Bañuls, S., González-Serna Martín, Manuel Alejandro, Pineda Vergara, Juan Antonio, Universidad de Sevilla. Departamento de Medicina, Universidad de Sevilla. Departamento de Fisiología, Consejería de Salud Junta de Andalucía, and Instituto de Salud Carlos III
- Subjects
Sustained virological response ,GWAS ,Hepatitis C virus infection ,Polymorphisms ,Direct-acting antivirals ,Liver stiffness - Abstract
Liver stiffness (LS) at sustained virological response (SVR) after direct-acting antivirals (DAA)-based therapy is a predictor of liver events in hepatitis C virus (HCV)-infected patients. The study aim was to identify genetic factors associated with LS changes from the moment of starting anti-HCV therapy to SVR. This prospective study included HCV-infected patients from the GEHEP 011 cohort who achieved SVR with DAA-based therapy, with LS pre-treatment ≥9.5 kPa and LS measurement available at SVR. Plink and Magma software were used to carry out genome-wide single-nucleotide polymorphism (SNP)-based and gene-based association analyses, respectively. The ShinyGO application was used for exploring enrichment in Gene Ontology (GO) categories for biological processes. Overall, 242 patients were included. Median (quartile 1, quartile 3) LS values at pre-treatment and at SVR were 16.8 (12, 28) kPa and 12.0 (8.5, 19.3) kPa, respectively. Thirty-five SNPs and three genes reached suggestive association with LS changes from the moment of starting anti HCV therapy to SVR. GO categories related to DNA packaging complex, DNA conformation change, chromosome organization and chromatin organization were significantly enriched. Our study reports possible genetic factors associated with LS changes during HCV-infection cure. In addition, our results suggest that processes related to DNA conformation are also involved in these changes.
- Published
- 2021
3. Kinetics of emergence of liver complications in hepatitis C virus infected patients and advanced fibrosis, with and without HIV-coinfection, after sustained virological response
- Author
-
Corma-Gómez A, Macías J, Téllez F, Morano L, Rivero A, Serrano M, Ríos MJ, Vera-Méndez FJ, Santos M, Real LM, Palacios R, Santos IL, Geijo P, Imaz A, Merino D, Galindo MJ, Reus-Bañuls S, López-Ruz MÁ, Galera C, Pineda JA, and RIS-HEP13 and GEHEP 011 study groups
- Subjects
hepatitis C virus ,liver decompensation ,HIV/hepatitis C virus-coinfection ,hepatocellular carcinoma ,sustained virological response ,direct-acting antivirals - Abstract
OBJECTIVE: There is scarce available evidence on the distribution over time of liver complications emergence in hepatitis C virus (HCV)-infected patients who achieve sustained virological response (SVR) with direct-acting antiviral (DAA)-based therapy. Therefore, we aimed at describing the kinetics of liver-related events appearance in this setting. DESIGN: A multicentric prospective cohort study. METHODS: HCV-monoinfected and HIV/HCV-coinfected patients from GEHEP-011 cohort, whose inclusion criteria were had achieved SVR with DAA-based therapy; liver stiffness prior to starting treatment at least 9.5 kPa; and available liver stiffness measurement at SVR. SVR was considered as the baseline time-point. RESULTS: One thousand and thirty-five patients were included, 664 (64%) coinfected with HIV. Before DAA-based therapy, 63 (6.1%) individuals showed decompensated cirrhosis. After SVR, 51 (4.9%) patients developed liver complications. Median (Q1-Q3) time to the emergence of hepatic events was hepatic encephalopathy 11 (7-24) months, ascites 14 (6-29) months, hepatocellular carcinoma (HCC) 17 (11-42) months and portal hypertension gastrointestinal bleeding (PHGB) 28 (22-38) months (P = 0.152). We define two profiles of liver complications: those emerging earlier (encephalopathy and ascites) and, those occurring continuously during the follow-up (HCC, PHGB) [median (Q1-Q3) time to emergence 12.7 (6.6-28.2) months vs. 25.4 (12.5-41.53) months, respectively (P = 0.026)]. CONCLUSION: The vast majority of HCV-infected patients who develop liver complications after reaching SVR with DAA do it within 3 years after SVR time-point. Specifically, hepatic encephalopathy and ascites do not usually emerge after this period. Conversely, HCC and PHGB may occur in longer term. It is critical to identify patients at risk of developing hepatic events to continue performing surveillance for them.
- Published
- 2021
4. A genome-wide association study on liver stiffness changes during hepatitis c virus infection cure
- Author
-
Universidad de Sevilla. Departamento de Medicina, Universidad de Sevilla. Departamento de Fisiología, Consejería de Salud Junta de Andalucía, Instituto de Salud Carlos III, Corma-Gómez, A, Macías Sánchez, Juan, Rivero, A., Rivero-Juárez, A., Santos, I. de los, Reus-Bañuls, S., González-Serna Martín, Manuel Alejandro, Pineda Vergara, Juan Antonio, Universidad de Sevilla. Departamento de Medicina, Universidad de Sevilla. Departamento de Fisiología, Consejería de Salud Junta de Andalucía, Instituto de Salud Carlos III, Corma-Gómez, A, Macías Sánchez, Juan, Rivero, A., Rivero-Juárez, A., Santos, I. de los, Reus-Bañuls, S., González-Serna Martín, Manuel Alejandro, and Pineda Vergara, Juan Antonio
- Abstract
Liver stiffness (LS) at sustained virological response (SVR) after direct-acting antivirals (DAA)-based therapy is a predictor of liver events in hepatitis C virus (HCV)-infected patients. The study aim was to identify genetic factors associated with LS changes from the moment of starting anti-HCV therapy to SVR. This prospective study included HCV-infected patients from the GEHEP 011 cohort who achieved SVR with DAA-based therapy, with LS pre-treatment ≥9.5 kPa and LS measurement available at SVR. Plink and Magma software were used to carry out genome-wide single-nucleotide polymorphism (SNP)-based and gene-based association analyses, respectively. The ShinyGO application was used for exploring enrichment in Gene Ontology (GO) categories for biological processes. Overall, 242 patients were included. Median (quartile 1, quartile 3) LS values at pre-treatment and at SVR were 16.8 (12, 28) kPa and 12.0 (8.5, 19.3) kPa, respectively. Thirty-five SNPs and three genes reached suggestive association with LS changes from the moment of starting anti HCV therapy to SVR. GO categories related to DNA packaging complex, DNA conformation change, chromosome organization and chromatin organization were significantly enriched. Our study reports possible genetic factors associated with LS changes during HCV-infection cure. In addition, our results suggest that processes related to DNA conformation are also involved in these changes.
- Published
- 2021
5. Evaluation of safety and tolerability of daptomycin in the treatment of osteomyelitis: results from a European Registry: O513
- Author
-
Seaton, R. A., Gargalianos-Kakolyris, P., Malizos, K., Romero-Candau, F., Carretta, A., Hernández-Quero, J., Militz, M., Reus Bañuls, S., Riccio, G., Heep, M., Thurston, H. J., and Chaves, R. L.
- Published
- 2010
6. Recomendaciones de expertos sobre el diagnóstico y tratamiento de la hepatitis C crónica en el medio penitenciario
- Author
-
Saiz de la Hoya-Zamácola, P., Marco-Touriño, A., Clemente-Ricote, G., Portilla-Sogorb, J., Boix-Martínez, V., Núñez-Martínez, Ó., Reus-Bañuls, S., and Teixidó i Pérez, N.
- Subjects
Prisiones ,Prisoners ,Prisons ,Reclusos ,VIH ,HIV ,Hepatitis C - Abstract
La prevalencia de la infección por el virus de la hepatitis C (VHC) en las prisiones españolas es muy elevada (38,5%). Las características de los pacientes infectados, especialmente la elevada coinfección con el virus de la inmunodeficiencia humana (VIH), hacen probable que la morbilidad y mortalidad producida por enfermedad hepática grave secundaria a esta infección aumente de forma considerable en los próximos años. Un grupo de expertos multidisciplinar con experiencia con pacientes internados en prisiones españolas ha sido invitado a establecer una serie de recomendaciones para el diagnóstico y tratamiento de la hepatitis C en las prisiones españolas. The prevalence of HCV infection in Spanish prisons is very high (38.5%). The characteristics of the infected patients, particularly the high rate of HIV coinfection, makes it very likely that the morbidity and mortality produced by serious liver disease secondary to this infection will increase considerably in the coming years. A group of Spanish experts with experience in patients who are inmates has been invited to establish a series of recommendations for the diagnosis and treatment of chronic hepatitis C infection in Spanish prisons.
- Published
- 2007
7. Histone carbonylation is a nuclear event with special relevance during cell proliferation and aging
- Author
-
García-GiménezȄ, J.L., primary, Bañuls, S., additional, Velázquez-Ledesma, A.M., additional, Pérez-Quilis, C., additional, Esmorís, I., additional, and Peiró-Chova et al, L., additional
- Published
- 2012
- Full Text
- View/download PDF
8. Meningitis associated with spinal anaesthesia: not always bacterial
- Author
-
Reus Bañuls, S., primary, Bustos Terol, S., additional, Olmos Soto, S., additional, and Piñar Cabezos, D., additional
- Published
- 2011
- Full Text
- View/download PDF
9. Meningitis asociada a anestesia espinal: no siempre bacteriana
- Author
-
Reus Bañuls, S., primary, Bustos Terol, S., additional, Olmos Soto, S., additional, and Piñar Cabezos, D., additional
- Published
- 2011
- Full Text
- View/download PDF
10. Papel del linezolid en el tratamiento de endocarditis
- Author
-
Caro Martínez, E., primary, Reus Bañuls, S., additional, López Rodríguez, C., additional, and Escorín Pérez, C., additional
- Published
- 2009
- Full Text
- View/download PDF
11. El curso clínico agresivo de la endocarditis neumocócica
- Author
-
Valero Novella, B., Reus Bañuls, S., Botella Ortiz, A., and Merino de Lucas, E.
- Published
- 2007
- Full Text
- View/download PDF
12. Paciente con osteomielitis crónica que desarrolla caquexia
- Author
-
Reus Bañuls, S., primary, Seguí Ripoll, J.M., additional, Escoín Pérez, C., additional, and Caro Martínez, E., additional
- Published
- 2007
- Full Text
- View/download PDF
13. Recomendaciones de expertos sobre el diagnóstico y tratamiento de la hepatitis C crónica en el medio penitenciario
- Author
-
Saiz de la Hoya-Zamácola, P., primary, Marco-Touriño, A., additional, Clemente-Ricote, G., additional, Portilla-Sogorb, J., additional, Boix-Martínez, V., additional, Núñez-Martínez, Ó., additional, Reus-Bañuls, S., additional, and Teixidó i Pérez, N., additional
- Published
- 2007
- Full Text
- View/download PDF
14. Long or complicated mpox in patients with uncontrolled HIV infection.
- Author
-
Corma-Gómez A, Cabello A, Orviz E, Morante-Ruiz M, Ayerdi O, Al-Hayani A, Muñoz-Gómez A, Santos IL, Gómez-Ayerbe C, Rodrigo D, Riestra SR, Reus-Bañuls S, Silva-Klug A, Galindo MJ, Santos M, Serrano-Fuentes M, Faro-Míguez N, Pérez-Camacho I, Corona-Mata D, Morano L, López-Ruz MÁ, Montero M, Anaya-Baz B, Merino D, Castillo-Navarro A, Pineda JA, and Macías J
- Subjects
- Humans, CD4 Lymphocyte Count, Disease Progression, RNA, HIV Infections, Mpox (monkeypox)
- Abstract
To date, former research about the impact of HIV infection on mpox poor outcomes is still limited and controversial. Therefore, the aim of this study was to assess the impact of HIV on the clinical course of mpox, in a large population of patients from Spain. Nationwide case-series study. Patients from 18 Spanish hospitals, with PCR-confirmed mpox from April 27, 2022 to June 30, 2023 were included in this study. The main outcome was the development of long or complicated (LC) mpox, defined as: (i) duration of the clinical course ≥ 28 days, or; (ii) disseminated disease, or: (iii) emergence of severe complications. One thousand eight hundred twenty-three individuals were included. Seven hundred eighty-six (43%) were people living with HIV (PLWH), of whom 11 (1%) had a CD4 cell count < 200 cells/mm
3 and 33 (3%) <350 cells/mm3 . HIV viral load ≥ 1000 cp/mL was found in 27 (3%) PLWH, none of them were on effective ART. Fifteen (60%) PLWH with HIV-RNA ≥ 1000 cp/mL showed LC versus 182 (29%) PLWH with plasma HIV-RNA load < 1000 copies/mL and 192 (24%) individuals without HIV infection (p < 0.001). In multivariate analysis, adjusted by age, sex, CD4 cell counts and HIV viral load at the time of mpox, only plasma HIV-RNA ≥ 1000 cp/mL was associated with a greater risk of developing LC mpox [adjusted OR = 4.06 (95% confidence interval 1.57-10.51), p = 0.004]. PLWH with uncontrolled HIV infection, due to lack of ART, are at a greater risk of developing LC mpox. Efforts should be made to ensure HIV testing is carried out in patients with mpox and to start ART without delay in those tested positive., (© 2024 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.)- Published
- 2024
- Full Text
- View/download PDF
15. IL7RA rs10491434 polymorphism is related to spontaneous HIV infection control in naïve HIV-infected patients: A retrospective study.
- Author
-
Sepúlveda-Crespo D, Jiménez-Sousa MA, Fernández-Rodíguez A, Muñoz-Fernández MA, Jiménez JL, Caraciolo BB, Reus Bañuls S, Vilchez H, Mothe B, Martínez I, Benito JM, Rallón N, and Resino S
- Subjects
- Humans, Disease Progression, Infection Control, Polymorphism, Single Nucleotide, Retrospective Studies, HIV Infections genetics, HIV Infections therapy, Interleukin-7 Receptor alpha Subunit genetics
- Abstract
Interleukin 7 receptor (IL7R) is vital in the adaptive immune response against human immunodeficiency viruses (HIV). We assessed IL7RA polymorphisms (SNPs) in antiretroviral therapy (ART)-naïve HIV patients for their association with spontaneous HIV infection control. We conducted a retrospective cohort study involving 667 ART-naïve patients categorized by HIV progression (ordinal variable): 150 rapid progressors, 334 moderate/typical progressors, 86 long-term nonprogressors elite controllers (LTNPs-EC), and 97 LTNPs-non-EC. We genotyped three IL7RA SNPs using Agena Bioscience's MassARRAY platform. The association between IL7RA SNPs and spontaneous HIV infection control was evaluated using ordinal logistic regression. Individuals carrying the rs10491434 G allele have a higher likelihood of spontaneous HIV infection control (adjusted odds ratio [aOR] = 1.33; p = 0.023). Moreover, the IL7RA GCT haplotype, consisting of three specific SNPs (rs6897932, rs987106, and rs10491434), demonstrated an association with the control of untreated HIV infection (aOR = 1.34; p = 0.050). Remarkably, the rs10491434 SNP and the IL7RA GCT haplotype exhibited similar aOR values, suggesting that rs10491434 may be primarily responsible for the observed effect of the haplotype. IL7RA rs10491434 G allele is associated with a higher likelihood of spontaneous HIV infection control, indicating its significant role in the pathogenesis of HIV, possibly influencing infection course and viral replication control., (© 2023 Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
16. A Risk Assessment Tool for Predicting Fragility Fractures in People with HIV: Derivation and Internal Validation of the FRESIA Model.
- Author
-
Vizcarra P, Moreno A, Vivancos MJ, Muriel García A, Ramirez Schacke M, González-Garcia J, Curran A, Palacios R, Sánchez Guirao AJ, Reus Bañuls S, Moreno Guillén S, and Casado JL
- Abstract
People with HIV have a higher risk of fracture than the general population. Because of the low performance of the existing prediction tools, there is controversy surrounding fracture risk estimation in this population. The aim of the study was to develop a model for predicting the long-term risk of fragility fractures in people with HIV. We included 11,899 individuals aged ≥30 years from the Spanish HIV/AIDS research network cohort. We identified incident fragility fractures from medical records, defined as nontraumatic or those occurring after a casual fall, at major osteoporotic sites (hip, clinical spine, forearm, proximal humerus). Our model accounted for the competing risk of death and included 12 candidate predictors to estimate the time to first fragility fracture. We assessed the discrimination and calibration of the model and compared it with the FRAX tool. The incidence rate of fragility fractures was 4.34 (95% CI 3.61 to 5.22) per 1000 person-years. The final prediction model included age, chronic kidney disease, and chronic obstructive pulmonary disease as significant predictors. The model accurately predicted the 5- and 10-year risk of fragility fractures, with an area under the receiving operator characteristic curve of 0.768 (95% CI 0.722 to 0.814) and agreement between the observed and expected probabilities. Furthermore, it demonstrated better discrimination and calibration than the FRAX tool, improving the classification of over 35% of individuals with fragility fractures compared to FRAX. Our prediction model demonstrated accuracy in predicting the long-term risk of fragility fractures. It can assist in making personalized intervention decisions for individuals with HIV and could potentially replace the current tools recommended for fracture risk assessment in this population. © 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR)., (© 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).)
- Published
- 2023
- Full Text
- View/download PDF
17. New contributions on chronic low back pain: disc infection or contaminated cultures?
- Author
-
Victoria MG, Gimeno-Gascón A, Ventero MP, Climent-Barberá JM, Cholbi-Llobell F, Rodríguez JC, Baño-Ruiz E, Caminero-Canas MA, and Reus-Bañuls S
- Subjects
- Humans, Cross-Sectional Studies, Magnetic Resonance Imaging, Propionibacterium acnes genetics, Low Back Pain diagnosis, Low Back Pain microbiology, Low Back Pain pathology, Intervertebral Disc microbiology, Intervertebral Disc pathology, Intervertebral Disc surgery, Gram-Positive Bacterial Infections microbiology
- Abstract
There is controversy about the likely infectious origin of chronic low back pain, because it has been suggested the possibility of a relationship with infection by Cutibacterium acnes (C. acnes). The aim of this study is to compare four methods to determine the presence of a likely infection caused by C. acnes in surgical disc samples. This work is a cross-sectional observational study in which there are included 23 patients with microdiscectomy indication. Disc samples were taken during surgery and analysis was done by culture, Sanger sequencing, next-generation sequencing (NGS), and real-time PCR (qPCR). Furthermore, clinical data collection was conducted, and it was analyzed the presence of the Modic-like changes on the magnetic resonance imaging. In 5 of the samples from among the 23 patients (21.7%), C. acnes was isolated by culture. However, in none of the samples could its genome be detected through Sanger sequencing, the less sensitive method. Only the qPCR and NGS were able to detect very few copies of the genome of this microorganism in all the samples, with no significant quantitative differences being observed between the patients in whom isolation of the microorganism by culture was evident or not. Furthermore, there were no significant relationships identified between the clinical variables, including Modic alterations and positive cultures. The most sensitive methods to the detect C. acnes were NGS and qPCR. The data obtained do not suggest association between the presence of C. acnes and the clinical process and support the hypothesis that C. acnes is found in these samples only because it is a contamination from the skin microbiome., (© 2023 Scandinavian Societies for Pathology, Medical Microbiology and Immunology.)
- Published
- 2023
- Full Text
- View/download PDF
18. Factors associated with malaria and arboviral disease in patients with imported febrile syndrome: a retrospective cohort study.
- Author
-
López-Amorós AI, Torrús-Tendero D, Merino de Lucas E, Reus Bañuls S, Boix Martínez V, Llorens Soriano P, Escribano Cañadas I, and Ramos-Rincón JM
- Subjects
- Humans, Fever epidemiology, Fever etiology, Headache, Retrospective Studies, Travel, Malaria diagnosis
- Abstract
Objectives: To identify predictors of malaria and arboviral disease in patients with febrile syndrome who seek care after traveling from tropical or subtropical locations., Material and Methods: Observational retrospective cohort study. We collected demographic, epidemiologic, and clinical data; laboratory findings; and the clinical and final microbiologic diagnoses. Multivariate analysis was used to calculate indices of diagnostic accuracy (sensitivity, specificity, and predictive values) and coefficients of probability of combinations of variables., Results: Data for 291 patients with febrile syndrome were included; 108 had malaria (37.1%), 28 had an arboviral disease (9.6%), and 155 had other causes of fever (53.3%). Multivariate analysis showed patients most likely to have malaria were those from sub-Saharan Africa, adjusted odds ratio (aOR) of 45.85 (95% CI, 9.45-222.49); immigrants who returned to visit friends and relatives (VFR), aOR of 3.55 (95% CI, 1.21-10.46); or had platelet concentrations 150 000/mm3, aORa of 16.47 (95% CI, 5.46-49.70) or headache, aOR of 10.62 (95% CI, 3.20-35.28). The combination of these 4 variables gave a positive probability coefficient (PPC) of 23.72 (95% CI, 5.76-97.62). Patients with febrile syndrome most likely to have an arboviral disease were those from Central or South America, OR 5.07 (95% CI, 1.73-14.92), and those who had exanthems, OR 5.10 (95% CI, 1.72-17.02) or joint pain, OR 14.50 (95% CI, 3.05-68.80). The combination of these 3 variables gave a PPC of 20.66 (95% CI, 7.74-55.21)., Conclusion: Patients with febrile syndrome with the greatest probability of having malaria are those from sub-Saharan Africa, those who are VFR, and those with platelet concentrations under 150.000/μL or headache. Arboviral disease was more likely in patients from Central and South America who had exanthems or joint pain.
- Published
- 2023
- Full Text
- View/download PDF
19. A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure.
- Author
-
Corma-Gómez A, Macías J, Rivero A, Rivero-Juarez A, de Los Santos I, Reus-Bañuls S, Morano L, Merino D, Palacios R, Galera C, Fernández-Fuertes M, González-Serna A, de Rojas I, Ruiz A, Sáez ME, Real LM, and Pineda JA
- Abstract
Liver stiffness (LS) at sustained virological response (SVR) after direct-acting antivirals (DAA)-based therapy is a predictor of liver events in hepatitis C virus (HCV)-infected patients. The study aim was to identify genetic factors associated with LS changes from the moment of starting anti-HCV therapy to SVR. This prospective study included HCV-infected patients from the GEHEP-011 cohort who achieved SVR with DAA-based therapy, with LS pre-treatment ≥ 9.5 kPa and LS measurement available at SVR. Plink and Magma software were used to carry out genome-wide single-nucleotide polymorphism (SNP)-based and gene-based association analyses, respectively. The ShinyGO application was used for exploring enrichment in Gene Ontology (GO) categories for biological processes. Overall, 242 patients were included. Median (quartile 1, quartile 3) LS values at pre-treatment and at SVR were 16.8 (12, 28) kPa and 12.0 (8.5, 19.3) kPa, respectively. Thirty-five SNPs and three genes reached suggestive association with LS changes from the moment of starting anti-HCV therapy to SVR. GO categories related to DNA packaging complex, DNA conformation change, chromosome organization and chromatin organization were significantly enriched. Our study reports possible genetic factors associated with LS changes during HCV-infection cure. In addition, our results suggest that processes related to DNA conformation are also involved in these changes.
- Published
- 2021
- Full Text
- View/download PDF
20. Infective endocarditis in elderly and very elderly patients.
- Author
-
Menchi-Elanzi M, Ramos-Rincón JM, Merino-Lucas E, Reus-Bañuls S, Torrús-Tendero D, Clíment-Paya V, Boix V, and Portilla-Sogorb J
- Subjects
- Age Distribution, Aged, Aged, 80 and over, Echocardiography, Humans, Middle Aged, Retrospective Studies, Spain epidemiology, Endocarditis epidemiology
- Abstract
Aims: To compare the clinical and epidemiological characteristics and the evolution of infective endocarditis in adults aged under 65 years, 65-79 years, and 80 years or older., Methods: An observational retrospective cohort study in patients with infective endocarditis was performed in a public hospital in Spain from January 2013 to December 2017., Results: Seventy-two patients were treated: 26 (36.1%) were under 65 years old, 28 (38.9%) were 65-79 years old, and 18 (25%) were aged 80 or older. Prosthetic valve endocarditis was less common in patients aged 65-79 years (3.6%) than in younger (23.1%; p = 0.047) or older (38.9%; p = 0.004) patients. In contrast, degenerative heart disease was more prevalent in the 65-79 year age group [64.3% compared to 15.4% (p < 0.001) in the youngest group, and 33.3% (p = 0.04) in the oldest]. Surgical interventions were similar in patients aged 65-79 (50%) and under 65 years (42.3%), but less common in people over 80 years (16.7%; p = 0.022)., Conclusions: The characteristics of infective endocarditis are different in patients aged 65-79 years and in those over 80 years.
- Published
- 2020
- Full Text
- View/download PDF
21. HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study.
- Author
-
Neukam K, Morano-Amado LE, Rivero-Juárez A, Mancebo M, Granados R, Téllez F, Collado A, Ríos MJ, de Los Santos-Gil I, Reus-Bañuls S, Vera-Méndez F, Geijo-Martínez P, Montero-Alonso M, Suárez-Santamaría M, and Pineda JA
- Subjects
- Female, Humans, Male, Middle Aged, Prospective Studies, Spain, Sustained Virologic Response, Treatment Outcome, Antiviral Agents therapeutic use, HIV Infections drug therapy, Hepatitis C, Chronic complications, Hepatitis C, Chronic drug therapy
- Abstract
Objective: HIV/HCV-coinfected patients and hepatitis C virus (HCV) monoinfected subjects are thought to respond equally to direct-acting antiviral (DAA)-based therapy despite the lack of data derived from clinical trials. This study is aimed to evaluate the impact of HIV coinfection on the response to DAA-based treatment against HCV infection in the clinical practice., Patients and Methods: In a prospective multicohort study, patients who initiated DAA-based therapy at the Infectious Disease Units of 33 hospitals throughout Spain were included. The primary efficacy outcome variables were the achievement of sustained virologic response 12 weeks after the scheduled end of therapy date (SVR12)., Results: A total of 908 individuals had reached the SVR12 evaluation time-point, 426 (46.9%) were HIV/HCV-coinfected, and 472 (52%) received interferon (IFN)-free therapy. In an intention-to-treat analysis, SVR12 rates in subjects with and without HIV-coinfection were 55.3% (94/170 patients) versus 67.3% (179/266 subjects; p = 0.012) for IFN-based treatment and 86.3% (221/256 subjects) versus 94.9% (205/216 patients, p = 0.002) for IFN-free regimens. Relapse after end-of-treatment response to IFN-free therapy was observed in 3/208 (1.4%) HCV-monoinfected subjects and 10/231 (4.4%) HIV/HCV-coinfected individuals (p = 0.075). In a multivariate analysis adjusted for age, sex, transmission route, body-mass index, HCV genotype, and cirrhosis, the absence of HIV-coinfection (adjusted odds ratio: 3.367; 95% confidence interval: 1.15-9.854; p = 0.027) was independently associated with SVR12 to IFN-free therapy., Conclusions: HIV-coinfection is associated with worse response to DAA-based therapy against HCV infection. In patients receiving IFN-free therapy, this fact seems to be mainly driven by a higher rate of relapses among HIV-coinfected subjects.
- Published
- 2017
- Full Text
- View/download PDF
22. [Cerebral toxoplasmosis in a patient with Waldenström's macroglobulinemia].
- Author
-
Olmos Soto S, Reus Bañuls S, Mora Castera E, and Villarubia Lor MB
- Subjects
- Aged, Antiprotozoal Agents therapeutic use, Biopsy, Cross Infection complications, Drug Therapy, Combination, Fatal Outcome, Humans, Immunosuppressive Agents adverse effects, Immunosuppressive Agents therapeutic use, Magnetic Resonance Imaging, Male, Multiple Organ Failure etiology, Pneumonia complications, Pons parasitology, Pons pathology, Pyrimethamine therapeutic use, Sulfadiazine therapeutic use, Toxoplasma isolation & purification, Toxoplasmosis, Cerebral diagnosis, Toxoplasmosis, Cerebral drug therapy, Toxoplasmosis, Cerebral parasitology, Waldenstrom Macroglobulinemia drug therapy, Toxoplasmosis, Cerebral complications, Waldenstrom Macroglobulinemia complications
- Published
- 2014
- Full Text
- View/download PDF
23. Oxidative stress and antioxidant response in fibroblasts from Werner and atypical Werner syndromes.
- Author
-
Seco-Cervera M, Spis M, García-Giménez JL, Ibañez-Cabellos JS, Velázquez-Ledesma A, Esmorís I, Bañuls S, Pérez-Machado G, and Pallardó FV
- Subjects
- Adolescent, Adult, Aging, Premature genetics, Aging, Premature metabolism, Aging, Premature pathology, Antioxidants metabolism, Case-Control Studies, Cell Line, Cell Proliferation, Child, Exodeoxyribonucleases genetics, Female, Fibroblasts metabolism, Fibroblasts pathology, Glutathione metabolism, Humans, Lamin Type A genetics, Male, Mutation, Progeria genetics, Progeria metabolism, Progeria pathology, RNA, Messenger genetics, RNA, Messenger metabolism, RecQ Helicases genetics, Superoxide Dismutase genetics, Superoxide Dismutase metabolism, Superoxide Dismutase-1, Werner Syndrome genetics, Werner Syndrome pathology, Werner Syndrome Helicase, Oxidative Stress, Werner Syndrome metabolism
- Abstract
Werner Syndrome (WS, ICD-10 E34.8, ORPHA902) and Atypical Werner Syndrome (AWS, ICD-10 E34.8, ORPHA79474) are very rare inherited syndromes characterized by premature aging. While approximately 90% of WS individuals have any of a range of mutations in theWRN gene, there exists a clinical subgroup in which the mutation occurs in the LMNA/C gene in heterozygosity. Although both syndromes exhibit an age-related pleiotropic phenotype, AWS manifests the onset of the disease during childhood, while major symptoms in WS appear between the ages of 20 and 30. To study the molecular mechanisms of progeroid diseases provides a useful insight into the normal aging process. Main changes found were the decrease in Cu/Zn and Mn SOD activities in the three cell lines. In AWS, both mRNA SOD and protein levels were also decreased. Catalase and glutathione peroxidases decrease, mainly in AWS. Glutaredoxin (Grx) and thioredoxin (Trx) protein expression was lower in the three progeroid cell lines. Grx and Trx were subjected to post-transcriptional regulation, because protein expression was reduced although mRNA levels were not greatly affected in WS. Low antioxidant defense and oxidative stress occur simultaneously in these rare genetic instability disorders at the onset of progeroid disease.
- Published
- 2014
- Full Text
- View/download PDF
24. [Association between inflammatory markers and microbial translocation in patients with human immunodeficiency virus infection taking antiretroviral treatment].
- Author
-
Reus Bañuls S, Portilla Sogorb J, Sanchez-Paya J, Boix Martínez V, Giner Oncina L, Frances R, Such J, Merino Lucas E, and Gimeno Gascón A
- Subjects
- Adult, Aged, Biomarkers, Cardiovascular Diseases epidemiology, Comorbidity, Cross-Sectional Studies, Diabetes Mellitus epidemiology, Dyslipidemias epidemiology, Female, HIV Infections drug therapy, HIV Infections epidemiology, HIV Infections microbiology, Hepatitis C, Chronic blood, Hepatitis C, Chronic epidemiology, Humans, Inflammation epidemiology, Inflammation microbiology, Male, Middle Aged, RNA, Bacterial genetics, RNA, Ribosomal, 16S genetics, Substance Abuse, Intravenous blood, Substance Abuse, Intravenous epidemiology, Young Adult, Anti-HIV Agents therapeutic use, Bacterial Translocation, Cytokines blood, DNA, Bacterial blood, DNA, Ribosomal blood, HIV Infections blood, Inflammation blood
- Abstract
Background and Objective: Inflammatory biomarkers are increased in patients with human immunodeficiency virus (HIV) infection. Antiretroviral treatment (ART) improves some parameters but do not normalize them. The aim of this study is to determine those factors (including microbial translocation) associated with higher inflammation in HIV treated patients., Patients and Methods: Transversal observational study., Inclusion Criteria: HIV patients receiving ART with an HIV viral load (VL)<400 copies/mL. Selection of patients: consecutively between November 2011 and January 2012. Main variable: plasma levels of interleukin 6 (IL-6) and tumour necrosis factor α (TNF-α). Main explanatory variable: microbial translocation markers (16S ribosomal DNA and sCD14). Patients with IL-6 or TNF-α levels above percentile 75 (group 1) were compared with the rest of patients (group 2). Odds ratio (OR) were determined., Results: Eighty-one patients were included (73% male, median age 45 years, 48% stage C). Twenty-six percent had chronic hepatitis C. Median CD4 cell was 493/mm(3) and 30% had detectable HIV VL. 16S ribosomal DNA was detected in 21% of patients. Factors associated with the higher levels of inflammatory markers were 16S ribosomal DNA (OR 77, P<.0001), sCD14 levels (P<.0001) and history of cardiovascular disease (OR 15, P<.01). In multivariate analysis, associations remained for 16S ribosomal DNA (OR 62, P<.0001) and previous cardiovascular disease (OR 25, P<.01)., Conclusions: In patients with HIV infection receiving treatment, the higher levels of inflammatory markers are associated with microbial translocation and past cardiovascular events., (Copyright © 2013 Elsevier España, S.L. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
25. [Cerebral aspergillosis in an human immunodeficiency virus infected patient].
- Author
-
Reus-Bañuls S, Bustos Terol S, Caro-Martínez E, and Cama-Barbieri J
- Subjects
- AIDS Serodiagnosis, AIDS-Related Opportunistic Infections drug therapy, AIDS-Related Opportunistic Infections microbiology, AIDS-Related Opportunistic Infections pathology, Adult, Anti-HIV Agents therapeutic use, Antifungal Agents therapeutic use, Brain Edema etiology, Cytomegalovirus Infections etiology, Female, HIV Infections diagnosis, HIV Infections drug therapy, Humans, Magnetic Resonance Imaging, Morocco ethnology, Neuroaspergillosis drug therapy, Neuroaspergillosis pathology, Serratia Infections etiology, Toxoplasmosis, Cerebral etiology, Triazoles therapeutic use, AIDS-Related Opportunistic Infections diagnosis, Neuroaspergillosis diagnosis
- Published
- 2012
- Full Text
- View/download PDF
26. [Meningitis associated with spinal anaesthesia: not always bacterial].
- Author
-
Reus Bañuls S, Bustos Terol S, Olmos Soto S, and Piñar Cabezos D
- Subjects
- Female, Humans, Male, Analgesics administration & dosage, Anesthesia, Spinal adverse effects, Injections, Spinal adverse effects, Meningitis, Bacterial etiology
- Published
- 2011
- Full Text
- View/download PDF
27. First fossil evidence of an "interglacial refugium" in the Pyrenean region.
- Author
-
López-García JM, Blain HA, Allué E, Bañuls S, Bargalló A, Martín P, Morales JI, Pedro M, Rodríguez A, Solé A, and Oms FX
- Subjects
- Altitude, Animals, Climate, Geography, Greenland, Ice, Ice Cover, Mediterranean Sea, Rodentia classification, Seasons, Spain, Vertebrates classification, Fossils
- Abstract
A refugium is generally understood as an area where temperate species survive cold periods, such as the Iberian, Italian, or Balkan Peninsulas in Europe. Strictly speaking, this definition refers to what is known as a glacial refugium. However, there are various types of lesser-known refugia such as the interglacial refugium, which denotes a mountainous region at low latitudes, such as the Pyrenees, where species adapted to the cold survive during interstadial periods. The small-vertebrate association from the sequence of Cova Colomera, which is located on the southern face of the Pyrenees and contains the final cold spell of the Late Pleistocene and the beginnings of the temperate period in which we currently find ourselves (the Holocene), could constitute the first fossil evidence of such an interglacial refugium, thus providing new paleoecological data on the phenomenon.
- Published
- 2010
- Full Text
- View/download PDF
28. [Role of linezolid in the treatment of endocarditis].
- Author
-
Caro Martínez E, Reus Bañuls S, López Rodríguez C, and Escorín Pérez C
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Linezolid, Male, Middle Aged, Retrospective Studies, Acetamides therapeutic use, Anti-Infective Agents therapeutic use, Endocarditis, Bacterial drug therapy, Oxazolidinones therapeutic use
- Published
- 2009
- Full Text
- View/download PDF
29. [Patient with chronic osteomyelitis who developed cachexia].
- Author
-
Reus Bañuls S, Seguí Ripoll JM, Escoín Pérez C, and Caro Martínez E
- Subjects
- Abscess complications, Adrenal Gland Diseases complications, Adrenal Insufficiency complications, Chronic Disease, Humans, Male, Middle Aged, Radiography, Soft Tissue Infections complications, Tuberculosis, Endocrine complications, Cachexia etiology, Osteomyelitis diagnostic imaging, Tuberculosis, Osteoarticular complications, Tuberculosis, Osteoarticular diagnostic imaging
- Published
- 2007
- Full Text
- View/download PDF
30. [Expert recommendations for the diagnosis and treatment of chronic hepatitis C infection in the prison setting].
- Author
-
Saiz de la Hoya-Zamácola P, Marco-Touriño A, Clemente-Ricote G, Portilla-Sogorb J, Boix-Martínez V, Núñez-Martínez O, Reus-Bañuls S, and Teixidó I Pérez N
- Abstract
The prevalence of HCV infection in Spanish prisons is very high (38.5%). The characteristics of the infected patients, particularly the high rate of HIV coinfection, makes it very likely that the morbidity and mortality produced by serious liver disease secondary to this infection will increase considerably in the coming years. A group of Spanish experts with experience in patients who are inmates has been invited to establish a series of recommendations for the diagnosis and treatment of chronic hepatitis C infection in Spanish prisons.
- Published
- 2007
- Full Text
- View/download PDF
31. [The aggressive clinical course of pneumococcal endocarditis].
- Author
-
Valero Novella B, Reus Bañuls S, Botella Ortiz A, and Merino de Lucas E
- Subjects
- Adolescent, Adult, Aged, Fatal Outcome, Female, Humans, Male, Middle Aged, Retrospective Studies, Endocarditis, Bacterial complications, Endocarditis, Bacterial diagnosis, Endocarditis, Bacterial surgery, Pneumococcal Infections complications, Pneumococcal Infections diagnosis, Pneumococcal Infections surgery
- Abstract
The aggressive clinical course of pneumococcal endocarditis. A retrospective study was conducted between 2000 and 2005 in five patients with pneumococcal endocarditis were diagnosed at our center. Three female and 2 males, 13 to 76 year-old, were attended. Most of them had left valve endocarditis and were suffering from predisposing conditions. All of them developed distant complications as embolism or septic metastases. Two patients were successfully operated. Surgery was considered in another one but it was discarded due to her poor general condition. This was the only death in the series.
- Published
- 2007
- Full Text
- View/download PDF
32. [Expert recommendations for the diagnosis and treatment of chronic hepatitis C infection in the prison setting].
- Author
-
Saiz de la Hoya-Zamácola P, Marco-Mouriño A, Clemente-Ricote G, Portilla-Sogorb J, Boix-Martínez V, Núñez-Martínez O, Reus-Bañuls S, and Teixidó i Pérez N
- Subjects
- HIV Infections, Humans, Substance Abuse, Intravenous, Hepatitis C, Chronic diagnosis, Hepatitis C, Chronic therapy, Prisons standards
- Abstract
The prevalence of HCV infection in Spanish prisons is very high (38.5%). The characteristics of the infected patients, particularly the high rate of HIV coinfection, makes it very likely that the morbidity and mortality produced by serious liver disease secondary to this infection will increase considerably in the coming years. A group of Spanish experts with experience in patients who are inmates has been invited to establish a series of recommendations for the diagnosis and treatment of chronic hepatitis C infection in Spanish prisons.
- Published
- 2006
- Full Text
- View/download PDF
33. [Bilateral papilloedema as the initial symptom of POEMS syndrome].
- Author
-
Martí-Martínez S, Martín-Estefanía C, Turpín-Fenoll L, Pampliega-Pérez A, Reus-Bañuls S, García-Barragán N, and Villarubia-Lor B
- Subjects
- Adult, Female, Humans, POEMS Syndrome complications, POEMS Syndrome diagnosis, Papilledema etiology
- Abstract
Introduction: Oedema of the papilla, or papilloedema, is usually due to intracranial hypertension, but can sometimes be the initial symptom of systemic diseases like Guillain-Barre syndrome, neurosarcoidosis, Leber's disease, Lyme disease or POEMS syndrome, among others. We report on a case that occurred at the Hospital General Universitario in Alicante, in which papilloedema was the initial symptom of POEMS syndrome., Case Report: A 36-year-old female, with no relevant past history, who visited after suffering a left-side frontal oppressive headache for five days; onset was sudden, there was no concomitant nausea or vomiting, it did not get worse when Valsalva manoeuvres were performed and there were no other accompanying symptoms. The examination revealed nasal blurring in the visual field of the right eye and papilloedema in the left eye, hyperpigmentation of the skin on the face and upper chest area that respected creases in the skin, painful distal tactile hypaesthesia in the lower limbs and bilateral areflexia of Achilles' tendons and patellar hyperreflexia. After conducting a number of different complementary tests intracranial space-occupying lesions and intracranial hypotension were both ruled out and the patient was diagnosed with mixed-type sensory-motor chronic polyneuropathy in the upper limbs, and in the lower extremities with predominantly distal involvement, bilateral oedema of the papilla and skin photosensitivity. Two years later the patient had hepatomegaly, subclinical hypothyroidism and sclerodermiform alterations of the skin, which suggested a probable diagnosis of POEMS syndrome that was later confirmed by the presence of monoclonal component in blood and urine., Conclusions: Papilloedema is rarely seen as the initial symptom of POEMS syndrome, but it must be included in the differential diagnosis of this pathology due to the diagnostic and therapeutic implications it entails.
- Published
- 2006
34. [Antiphospholipid antibodies in acute infection caused by hepatitis C virus].
- Author
-
Merino de Lucas E, Priego Valladares M, Reus Bañuls S, and Pérez-Mateo Regadera M
- Subjects
- Acute Disease, Adult, Antibodies, Anticardiolipin analysis, Humans, Immunoenzyme Techniques, Male, Antibodies, Antiphospholipid analysis, Hepatitis C immunology
- Published
- 1998
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.